Barrington Research Predicts Lower Earnings for HealthEquity

HealthEquity, Inc. (NASDAQ:HQY - Free Report) - Research analysts at Barrington Research reduced their Q2 2026 earnings per share (EPS) estimates for shares of HealthEquity in a report released on Thursday, June 5th. Barrington Research analyst A. Paris now forecasts that the company will post earnings per share of $0.72 for the quarter, down from their prior estimate of $0.73. Barrington Research currently has a "Outperform" rating and a $125.00 target price on the stock. The consensus estimate for HealthEquity's current full-year earnings is $2.32 per share. Barrington Research also issued estimates for HealthEquity's Q3 2026 earnings at $0.72 EPS and Q4 2026 earnings at $0.78 EPS.

Other research analysts have also issued research reports about the stock. KeyCorp reduced their price objective on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a research note on Wednesday, April 16th. JMP Securities lifted their price target on shares of HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a report on Wednesday, June 4th. Bank of America increased their price objective on HealthEquity from $110.00 to $125.00 and gave the company a "buy" rating in a report on Wednesday, June 4th. Deutsche Bank Aktiengesellschaft boosted their target price on HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a research note on Thursday, June 5th. Finally, Wall Street Zen upgraded HealthEquity from a "hold" rating to a "buy" rating in a research note on Friday, June 6th. One equities research analyst has rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, HealthEquity has an average rating of "Buy" and an average price target of $118.09.

HealthEquity Stock Down 0.5%

Shares of HQY stock traded down $0.57 during mid-day trading on Monday, hitting $103.99. 883,768 shares of the stock traded hands, compared to its average volume of 835,294. HealthEquity has a 52-week low of $65.01 and a 52-week high of $116.65. The stock has a market cap of $8.99 billion, a P/E ratio of 95.40, a P/E/G ratio of 1.60 and a beta of 0.49. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The stock's fifty day moving average is $92.93 and its two-hundred day moving average is $97.88.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, beating analysts' consensus estimates of $0.81 by $0.16. The company had revenue of $330.80 million for the quarter, compared to the consensus estimate of $322.25 million. HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter last year, the company earned $0.80 earnings per share.

Hedge Funds Weigh In On HealthEquity

Institutional investors and hedge funds have recently bought and sold shares of the business. Janney Montgomery Scott LLC lifted its stake in HealthEquity by 8.5% in the 4th quarter. Janney Montgomery Scott LLC now owns 5,352 shares of the company's stock worth $514,000 after purchasing an additional 420 shares in the last quarter. Entropy Technologies LP purchased a new stake in shares of HealthEquity in the fourth quarter valued at approximately $224,000. Peterson Wealth Services increased its holdings in shares of HealthEquity by 5.1% in the fourth quarter. Peterson Wealth Services now owns 10,507 shares of the company's stock valued at $1,008,000 after purchasing an additional 509 shares during the last quarter. Louisiana State Employees Retirement System lifted its position in HealthEquity by 0.4% during the fourth quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company's stock worth $2,322,000 after buying an additional 100 shares in the last quarter. Finally, Legato Capital Management LLC acquired a new position in HealthEquity during the fourth quarter worth $778,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, EVP Elimelech Rosner sold 58,000 shares of the firm's stock in a transaction on Friday, June 6th. The stock was sold at an average price of $112.56, for a total value of $6,528,480.00. Following the transaction, the executive vice president now owns 75,689 shares in the company, valued at approximately $8,519,553.84. This trade represents a 43.38% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Robert W. Selander sold 5,750 shares of the company's stock in a transaction on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total transaction of $446,487.50. Following the sale, the director now directly owns 84,969 shares of the company's stock, valued at $6,597,842.85. The trade was a 6.34% decrease in their position. The disclosure for this sale can be found here. Insiders sold 304,581 shares of company stock valued at $33,664,018 over the last quarter. 1.50% of the stock is currently owned by insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.